Organigram Dramatically Ups Its Investment Into Biosynthesized Cannabis Products

Organigram Dramatically Ups Its Investment Into Biosynthesized Cannabis Products

OrganiGram Holdings (NASDAQ: OGI) is helping to push the boundaries of the cannabis industry. The company announced Monday that it is making a fresh $2.5 million investment into Hyasynth Biologicals, a biotech that uses biosynthesis to manufacture cannabinoids. The deal is part of an arrangement the two companies have, under which OrganiGram may provide three tranches of investment to the privately held Hyasynth.